text

Wuhan's promising anti-coronavirus drug trial gains WHO recognition

The double-blind randomized controlled trial (RCT) of the antiviral drug Remdesivir, a possible treatment of the novel coronavirus, is underway in Wuhuan, and received recognition from the World H